Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

CYTR

CytRx (QB) (CYTR)

CytRx Corp (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:CYTR
DataHoraFonteTítuloCódigoCompanhia
26/06/202307:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CYTRCytRx Corp (QB)
15/05/202307:29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CYTRCytRx Corp (QB)
20/03/202307:08Edgar (US Regulatory)Annual Report (10-k)USOTC:CYTRCytRx Corp (QB)
14/02/202315:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CYTRCytRx Corp (QB)
28/07/202220:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CYTRCytRx Corp (QB)
28/07/202217:06Edgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (d/a)USOTC:CYTRCytRx Corp (QB)
16/06/202217:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CYTRCytRx Corp (QB)
16/06/202207:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CYTRCytRx Corp (QB)
03/06/202217:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CYTRCytRx Corp (QB)
19/05/202218:04Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:CYTRCytRx Corp (QB)
28/03/202207:05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CYTRCytRx Corp (QB)
25/03/202217:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:CYTRCytRx Corp (QB)
15/02/202208:30Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CYTRCytRx Corp (QB)
12/01/202212:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CYTRCytRx Corp (QB)
04/08/202117:31Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CYTRCytRx Corp (QB)
29/07/202107:08Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:CYTRCytRx Corp (QB)
13/07/202107:01Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CYTRCytRx Corp (QB)
18/06/202113:07Dow Jones NewsOrphazyme, CytRx Shares Slide as FDA Rejects ArimoclomolUSOTC:CYTRCytRx Corp (QB)
22/04/202107:16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:CYTRCytRx Corp (QB)
17/11/202008:11Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-a12g/a)USOTC:CYTRCytRx Corp (QB)
23/10/202008:43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:CYTRCytRx Corp (QB)
25/08/202011:12Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:CYTRCytRx Corp (QB)
13/08/202010:30Edgar (US Regulatory)Proxy Statement - Non-management (definitive) (defn14a)USOTC:CYTRCytRx Corp (QB)
10/08/202009:56Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prrn14a)USOTC:CYTRCytRx Corp (QB)
10/08/202007:05Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)USOTC:CYTRCytRx Corp (QB)
20/07/202010:27Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)USOTC:CYTRCytRx Corp (QB)
27/05/202007:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:CYTRCytRx Corp (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:CYTR